<?xml version="1.0"?>
  <rss version="2.0">
    <channel>
      <title>Endometriosis News : GoldBamboo.com</title>
      <link>http://goldbamboo.com/</link>
      <description>Endometriosis News from GoldBamboo.com</description>
      <language>en-us</language>
      <copyright>&amp;copy; 2005, Gold Bamboo LLC, All Rights Reserved</copyright>
      
	<item>
        <title>Endometriosis doesn't raise fracture risk</title>
        <link>http://goldbamboo.com/news-a213897.html</link>
        <description>NEW YORK (Reuters Health) - A couple of previous studies have indicated that women with endometriosis may not develop strong bones, but a new report shows that the condition does not increase the long-term risk of suffering a fracture.</description>
		 <pubDate>Thu, 04 Jan 2007 03:20 EST</pubDate>
	</item>
	<item>
        <title>Endometriosis Diagnosis, Treatment Increasing For Young Women</title>
        <link>http://goldbamboo.com/news-a205039.html</link>
        <description>Endometriosis -- a condition in which the tissue that normally lines the uterus develops in other parts of the body -- is increasingly being diagnosed in young women, and while physicians are improving treatments for such women, they "don't always work," the Boston Globe reports. According to NIH, about 5. [click link for full article]</description>
		 <pubDate>Fri, 03 Nov 2006 05:00 EST</pubDate>
	</item>
	<item>
        <title>Different uterine disorders often coexist</title>
        <link>http://goldbamboo.com/news-a203724.html</link>
        <description>NEW YORK (Reuters Health) - Persistent pelvic pain after surgery for endometriosis suggests the presence of another uterine disorder called adenomyosis, according to a report in the journal Fertility and Sterility.</description>
		 <pubDate>Wed, 25 Oct 2006 12:35 EST</pubDate>
	</item>
	<item>
        <title>Neurocrine Biosciences Announces Results From Follow-Up Phase II Study With Its Orally Active GnRH Receptor Antagonist In Endometriosis</title>
        <link>http://goldbamboo.com/news-a197911.html</link>
        <description> Neurocrine Biosciences,Inc. (Nasdaq: NBIX) today announced positive safety and efficacy resultswith completion of the second off-treatment 3-month period of its 6-month'proof of concept', safety, efficacy and dose-finding Phase II clinicaltrial using its proprietary, orally-active small moleculeGonadotropin-Releasing Hormone (GnRH) receptor antagonist (NBI-56418). [click link for full article]</description>
		 <pubDate>Wed, 13 Sep 2006 07:00 EST</pubDate>
	</item>
	<item>
        <title>Hope for treatment of endometriosis</title>
        <link>http://goldbamboo.com/news-a190895.html</link>
        <description>Scientists say they have made a "crucial step" forwards in understanding treating endometriosis.</description>
		 <pubDate>Wed, 26 Jul 2006 11:58 EST</pubDate>
	</item>
	

    </channel>
  </rss>
